Candriam SCA’s Design Therapeutics DSGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-225,000	Closed	-$596K	–	706
2023 Q4	$596K	Hold	225,000	–	–	﹤0.01%	645
2023 Q3	$531K	Buy	225,000 +40,000	+22%	+$94.4K	﹤0.01%	620
2023 Q2	$1.17M	Buy	+185,000	New	+$1.17M	0.01%	587